Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Different polarization and functionality of CD4+ T helper subsets in people with post-COVID condition.
Sánchez-Menéndez C, de la Calle-Jiménez O, Mateos E, Vigón L, Fuertes D, Murciano Antón MA, San José E, García-Gutiérrez V, Cervero M, Torres M, Coiras M. Sánchez-Menéndez C, et al. Among authors: murciano anton ma. Front Immunol. 2024 Aug 27;15:1431411. doi: 10.3389/fimmu.2024.1431411. eCollection 2024. Front Immunol. 2024. PMID: 39257580 Free PMC article.
Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV.
Rodríguez-Mora S, Sánchez-Menéndez C, Bautista-Carrascosa G, Mateos E, Moreno-Serna L, Megías D, Cantón J, García-Gutiérrez V, Murciano-Antón MA, Cervero M, Spivak A, Planelles V, Coiras M. Rodríguez-Mora S, et al. Among authors: murciano anton ma. Biochem Pharmacol. 2024 Nov;229:116512. doi: 10.1016/j.bcp.2024.116512. Epub 2024 Sep 1. Biochem Pharmacol. 2024. PMID: 39222713 Free article.
Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus.
Casado-Fernández G, Cantón J, Nasarre L, Ramos-Martín F, Manzanares M, Sánchez-Menéndez C, Fuertes D, Mateos E, Murciano-Antón MA, Pérez-Olmeda M, Cervero M, Torres M, Rodríguez-Rosado R, Coiras M. Casado-Fernández G, et al. Among authors: murciano anton ma. Front Immunol. 2024 May 15;15:1362621. doi: 10.3389/fimmu.2024.1362621. eCollection 2024. Front Immunol. 2024. PMID: 38812512 Free PMC article.
Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19.
Rodríguez-Mora S, Corona M, Solera Sainero M, Mateos E, Torres M, Sánchez-Menéndez C, Casado-Fernández G, García-Pérez J, Pérez-Olmeda M, Murciano-Antón MA, López-Jiménez J, Coiras M, García-Gutiérrez V. Rodríguez-Mora S, et al. Among authors: murciano anton ma. Cancers (Basel). 2023 Oct 20;15(20):5066. doi: 10.3390/cancers15205066. Cancers (Basel). 2023. PMID: 37894433 Free PMC article.
Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination.
Rodríguez-Mora S, Pérez-Lamas L, Sainero MS, Torres M, Sánchez-Menéndez C, Corona M, Mateos E, Casado-Fernández G, Alcamí J, García-Pérez J, Pérez-Olmeda M, Murciano-Antón MA, López-Jiménez J, García-Gutiérrez V, Coiras M. Rodríguez-Mora S, et al. Among authors: murciano anton ma. Cancers (Basel). 2023 Apr 18;15(8):2344. doi: 10.3390/cancers15082344. Cancers (Basel). 2023. PMID: 37190272 Free PMC article.
Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster.
Torres M, Corona M, Rodríguez-Mora S, Casado-Fernández G, Zurdo-Castronuño A, Mateos E, Ramos-Martín F, Sánchez-Menéndez C, Murciano-Antón MA, García-Pérez J, Alcamí J, Pérez-Olmeda M, Coiras M, López-Jiménez J, García-Gutiérrez V, On Behalf Of The Multidisciplinary Group Of Study Of Covid-Mgs-Covid. Torres M, et al. Among authors: murciano anton ma. Cancers (Basel). 2022 Nov 10;14(22):5537. doi: 10.3390/cancers14225537. Cancers (Basel). 2022. PMID: 36428631 Free PMC article.
Association between HLA-C alleles and COVID-19 severity in a pilot study with a Spanish Mediterranean Caucasian cohort.
Vigón L, Galán M, Torres M, Martín-Galiano AJ, Rodríguez-Mora S, Mateos E, Corona M, Malo R, Navarro C, Murciano-Antón MA, García-Gutiérrez V, Planelles V, Martínez-Laso J, López-Huertas MR, Coiras M; Multidisciplinary Group of Study of COVID-19 (MGS-COVID). Vigón L, et al. Among authors: murciano anton ma. PLoS One. 2022 Aug 12;17(8):e0272867. doi: 10.1371/journal.pone.0272867. eCollection 2022. PLoS One. 2022. PMID: 35960731 Free PMC article.
How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention.
Del Cura-González I, López-Rodríguez JA, Leiva-Fernández F, Gimeno-Miguel A, Poblador-Plou B, López-Verde F, Lozano-Hernández C, Pico-Soler V, Bujalance-Zafra MJ, Gimeno-Feliu LA, Aza-Pascual-Salcedo M, Rogero-Blanco M, González-Rubio F, García-de-Blas F, Polentinos-Castro E, Sanz-Cuesta T, Castillo-Jimena M, Alonso-García M, Calderón-Larrañaga A, Valderas JM, Marengoni A, Muth C, Prados-Torres JD, Prados-Torres A; Multi-Pap Group. Del Cura-González I, et al. J Pers Med. 2022 May 6;12(5):752. doi: 10.3390/jpm12050752. J Pers Med. 2022. PMID: 35629175 Free PMC article.
Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19.
Rodríguez-Mora S, Corona M, Torres M, Casado-Fernández G, García-Pérez J, Ramos-Martín F, Vigón L, Manzanares M, Mateos E, Martín-Moro F, Zurdo-Castronuño A, Murciano-Antón MA, Alcamí J, Pérez-Olmeda M, López-Jiménez J, García-Gutiérrez V, Coiras M, On Behalf Of The Multidisciplinary Group Of Study Of Covid-Mgs-Covid. Rodríguez-Mora S, et al. Among authors: murciano anton ma. J Clin Med. 2022 May 16;11(10):2803. doi: 10.3390/jcm11102803. J Clin Med. 2022. PMID: 35628927 Free PMC article.
18 results